Dutch Healthcare Authority published the third release of the DRG package for 2021

24

Nov 2020

On November 5, 2020, the Dutch Healthcare Authority (NZa) published the third release of the DRG package for the 2021 (RZ21c) to implement reimbursement for extra beds in intensive care and added the pathway for new optional add-on services.

The Ministry of Health, Welfare and Sport (VWS) has established a subsidy scheme for the accelerated expansion of the national capacity of IC bed. The NZa added two additional add-on services with a reduced tariff of €0.01 for the registration of IC days if the regular capacity of IC beds is exceeded:

  • 190159 IC day, VWS subsidy upscaling phase 2;
  • 190160 IC day, VWS subsidy upscaling phase 3.

By 2021, healthcare providers and health insurers can jointly apply for an optional service for specialist medical care from the Dutch Healthcare Authority (NZa). These services have a fast application procedure and can be implemented during the year. In the RZ21c release of the DRG package, the NZa implemented two types of optional services with specific procedure codes:

  • Regular optional supplementary services (codes 198500-198699): these services can be provided independently of other care, separately from DRG. It offers a free form for reimbursement of care when no DRG care pathway has been opened.
  • Optional add-ons (codes 198700-198799): for these services, additional reimbursement (for example, incurred in an innovation) can be obtained in addition to the DRG tariff. The add-on service always belongs to the DRG care pathway.

The full details in Dutch can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more